SINGAPORE, May 23, 2024 /PRNewswire/ -- MediThinQ, the
Korean startup pioneering extended reality (XR) wearable displays
for surgical applications, unveils its groundbreaking SCOPEYE 3D
Micro Surgery Solution. This innovative microsurgery solution
leverages the latest Eyes Up Display technology to enhance
precision across medical specialties, revolutionising depth
perception and spatial awareness without the need for
eyepieces.
The SCOPEYE 3D Micro Surgery Solution comprises the SCOPEYE Eyes
Up wearable display, the 3D Microvision, a light and portable
high-performance 3D digital microscope, and the 3D AddON, a device
that elevates conventional 2D microscopes to advanced 3D
capabilities. Offering exceptional performance, mobility, and space
efficiency while maintaining a minimalist design aesthetic, it
empowers surgeons to perform 3D procedures wherever needed. Its
portability makes it ideal for a wide range of applications,
including microsurgery, plastic surgery, dental procedures,
ophthalmology, hair transplant surgery, and dermatology.
The benefits of the SCOPEYE 3D Micro Surgery Solution are
manifold. With high-resolution 3D optics, surgeons gain
unparalleled visual clarity and depth perception, enhancing their
precision and accuracy during procedures. Additionally, the
solution offers significant cost efficiencies, maximised ergonomic
comfort, and advanced features such as 3D recording and training
capabilities, further enhancing patient care and surgical
outcomes.
Propelling MediThinQ's growth forward, Chris Lee, Founder & CEO of VentureBlick,
assumes the role Chairman of the Board of MediThinQ, marking a
pivotal moment in MediThinQ's journey. With a remarkable 30-year
career spanning top global pharmaceutical and medtech companies,
Chris brings extensive experience and leadership to the table.
In a strategic move to deepen their collaboration, MediThinQ and
VentureBlick have entered a cross-ownership agreement. With this
arrangement, both companies will own stakes in each other's shares,
reaffirming their commitment to mutual advancement and success.
MediThinQ and VentureBlick's partnership began when MediThinQ
joined VentureBlick's Super Incubator programme. With
VentureBlick's support, MediThinQ achieved key milestones. Now,
their bond has deepened even further, marking a significant moment
for both companies.
Chris Lee, Founder & CEO of
VentureBlick said: "MediThinQ's solutions deliver tangible medical
value, and we are thrilled to collaborate with them on an even
deeper level to enhance surgical visualisation, ultimately leading
to improved patient outcomes. Our partnership will accelerate
MediThinQ's growth further and pave the way for pioneering
advancements in the field of extended reality for surgical
applications."
Seungjoon Im, Founder & CEO
of MediThinQ, said: "Our SCOPEYE 3D Mirco Surgery Solution sets a
new standard and is a strong addition to our offerings as we ramp
up our global commercialisation efforts. We're grateful to Chris
for accepting the role of Chairman of our Board. With his vast
international experience, he is the undoubtedly the ideal person to
bring MediThinQ to new heights."
MediThinQ's journey from a visionary startup to a global leader
is marked by significant milestones. As the first Asian startup to
globally launch XR surgical displays, the company has garnered
attention and accolades worldwide. Securing major deals with
industry giants in the USA,
Japan, Australia, and Europe, is a testament to the quality and
effectiveness of MediThinQ's offerings, positioning the company as
a frontrunner in the global healthcare landscape.
MediThinQ is currently raising its Series B fund while exploring
IPO options in Korea, Singapore,
Hong Kong SAR, and North America.
It is setting the stage for potential early exits through strategic
acquisitions or accelerated commercial growth.
Photo -
https://mma.prnewswire.com/media/2415784/The_MediThinQ_SCOPEYE_3D_Micro_Surgery_Solution.jpg
View original content to download
multimedia:https://www.prnewswire.co.uk/news-releases/medithinq-unveils-scopeye-3d-micro-surgery-solution-chris-lee-of-ventureblick-assumes-chairmanship-302148815.html